Clinical Insights into the Management of Mixed Dyslipidemia: Targeting Hypertriglyceridemia to Reduce Cardiovascular Disease Risk

Satellite Dinner Symposium
Friday, May 30, 2008
7:00—9:00 p.m. in Grand Ballroom 1

Overview
While it is well recognized that LDL plays an important role in atherogenesis and CVD risk, advances in our scientifi c understanding of other lipoproteins including HDL-C, non-HDL-C, and triglycerides have allowed clinicians to further reduce CVD risk. This educational program will update you on the evolving science of triglycerides and present the most recent evidence-based clinical trials concerning hypertriglyceridemia. An expert faculty will evaluate and discuss the application of these important data to improve the outcomes of your patients with cardiovascular disease.

Intended Audience
This activity is attended for physicians, physician assistants, pharmacists, nurses, nurse practitioners, and registered dieticians interested in cardiovascular disease. In accordance with PhRMA, this program is intended for healthcare professionals only.

Learning Objectives
Upon completion of this activity, participants should be able to:

Discuss principal sources of coronary risk within the overall lipid profile
Identify surveys which have assessed lipid goals, review NCEP and ATP III guidelines and identify barriers to achieving optimal lipid and triglyceride profiles
Assess how levels of apolipoproteins, lipoprotein particle size and number, HDL-c, non-HDL-c, and triglycerides play a role in coronary risk and discuss effective measurement and treatment options
Evaluate the role of statins, niacin, fibrates and omega-3 fatty acids in the management of the lipid profile and treatment of dyslipidemia and hypertriglyceridemia

Course Chair
Michael Miller, MD
Associate Professor of Medicine
Epidemiology and Preventive Medicine
University of Maryland School of Medicine
Director, Center for Preventive Cardiology
University of Maryland Medical Center
Baltimore, MD

Faculty
Alan S. Brown, MD, FACC
Interventional Cardiologist
Midwest Heart Specialists
Director, Midwest Heart Disease Prevention Center
Naperville, IL

Karol E. Watson, MD, PhD, FACC
Co-Director, UCLA
Program in Preventive Cardiology
Geffen School of Medicine at UCLA
Los Angeles, CA

Agenda

7:00 - 7:30 pm Registration and Dinner
7:30 - 7:35 Introduction - Michael Miller, MD
7:35 - 7:50 Targeting Mixed Dyslipidemia to Reduce CVD Risk - Karol E. Watson, MD, PhD, FACC
7:50 - 8:00 Panel Discussion
8:00 - 8:15 Triglyceride Science and the Mechanisms of Atherosclerosis - Michael Miller, MD
8:15 - 8:25 Panel Discussion
8:25 - 8:40 Current Concepts in the Management of Patients with Hypertriglyceridemia - Alan S. Brown, MD, FACC
8:40 - 8:50 Panel Discussion
8:50 - 9:00 Question and Answer Session

Accreditation
CME credit provided by the National Lipid Association.

Physicians:
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Lipid Association designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category I Credit™ from organizations accredited by ACCME. CE credit provided by the Institute for Continuing Healthcare.

CE credit provided by the Institute for Continuing Healthcare Education.

Education Nurses
The Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity offers 1.5 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers. Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA. Jacqueline Dawson, MSN, RN is the nurse planner for this activity.

Dietitians:
This program is cosponsored by the Institute for Continuing Healthcare Education and the National Lipid Association .The Institute for Continuing Healthcare Education; provider number IN003 is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR) from March 28, 2007 to March 27, 2010. Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 2 continuing professional education units (CPEUs) for completion of this Level 2 program. Continuing Professional Education Provider Accreditation does not constitute endorsement by the CDR of a provider, program, or materials.

Pharmacists
This program is cosponsored by the Institute for Continuing Healthcare Education and the National Lipid Association .The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education .This program is acceptable for 1.5 (0.15) of continuing education credit in states that recognize ACPE–accredited providers (ACPE ID # 781-999-08-024-L01-P).

Faculty Disclosure Statement
The National Lipid Association and the Institute for Continuing Healthcare Education Nurses adhere to ACCME essential areas and policies regarding industry support of continuing medical education. Disclosure of faculty and commercial relationships, if any, will be included in the syllabus.

This activity is supported by an educational grant from GlaxoSmithKline.